You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

anti-leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Acute Myeloid Leukemia, in Relapse
  • anti Tim-3/CD123 CAR-T cell therapy
  • Xuzhou, Jiangsu, China
    Kailin Xu
Nov 4, 2023

Anti-mullerian Hormone in Acute Lymphoblastic Leukemia

Recruiting
  • Acute Lymphoblastic Leukemia
    • Trieste, Italy
      IRCCS Burlo Garofolo
    Mar 20, 2023

    Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)

    Not yet recruiting
    • Acute Myeloid Leukemia, in Relapse
    • Acute Myeloid Leukemia Refractory
    • (no location specified)
    Nov 9, 2023

    Extranodal NK T Cell Lymphoma, NK-Cell Leukemia Trial in Xuzhou (Anti-CD56 CAR T)

    Recruiting
    • Extranodal NK T Cell Lymphoma
    • NK-Cell Leukemia
    • Anti-CD56 CAR T
    • Xuzhou, Jiangsu, China
      The Affiliated Hospital of Xuzhou Medical University
    Jul 10, 2023

    Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia, Lymphoma, B-Cell Trial run by the National Cancer Institute

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • +2 more
    • Anti-CD19 and anti-CD20 bicistronic CAR T- cells
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Apr 10, 2023

    Acute T-lymphoblastic Leukemia, Acute T-lymphoblastic Lymphoma Trial in Xuzhou (CAR-T Cell Infusion)

    Recruiting
    • Acute T-lymphoblastic Leukemia
    • Acute T-lymphoblastic Lymphoma
    • CAR-T Cell Infusion
    • Xuzhou, Jiangsu, China
      The Affiliated Hospital of Xuzhou Medical University
    Feb 23, 2023

    Acute Myeloid Leukemia Trial in Fuzhou (CLL1/+CD33 CAR-T)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • CLL1/+CD33 CAR-T
    • Fuzhou, Fujian, China
      Fujian Provincial Children's Hospital
    Jul 10, 2023

    Chronic Lymphocytic Leukemia Trial (Loncastuximab Tesirine)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Loncastuximab Tesirine
    • (no location specified)
    Jul 24, 2023

    Acute Myeloid Leukemia, Myeloid Leukemia, Recurrent Acute Myeloid Leukemia Trial in Houston (Biopsy, Biospecimen Collection,

    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Biopsy
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 9, 2021

    Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti-siglec-6 CAR-T cell therapy)

    Recruiting
    • Acute Myeloid Leukemia Refractory
    • Acute Myeloid Leukemia, in Relapse
    • anti-siglec-6 CAR-T cell therapy
    • Xuzhou, Jiangsu, China
      Kailin Xu
    Aug 2, 2022

    Acute Myeloid Leukemia, Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Anti-CD33 CAR

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Anti-CD33 CAR T-cells
    • Lymphodepletion Therapy
    • Duarte, California
      City of Hope Medical Center
    Jan 3, 2023

    Hairy Cell Leukemia, Hairy Cell Leukemia Variant Trial run by the NCI (CD22CART cell infusion)

    Recruiting
    • Hairy Cell Leukemia
    • Hairy Cell Leukemia Variant
    • CD22CART cell infusion
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse, Refractory Acute Lymphoblastic Leukemia Trial in Beijing

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +2 more
    • Autologous humanized anti-CD22 chimeric antigen receptor T cells
    • Beijing, Beijing, China
      Beijing Boren Hospital
    Aug 12, 2022

    Acute Myeloid Leukemia Trial in Wuhan (Fludarabine + Cyclophosphamide + TAA05 Cell Injection)

    Recruiting
    • Acute Myeloid Leukemia
    • Fludarabine + Cyclophosphamide + TAA05 Cell Injection
    • Wuhan, Hubei, China
      Wuhan Union Hospital
    Jun 29, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Columbus (Pneumococcal 13-valent Conjugate Vaccine,

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Pneumococcal 13-valent Conjugate Vaccine
    • Pneumococcal Polyvalent Vaccine
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Nov 10, 2022

    B-Cell Non Hodgkin Lymphoma, B-Cell Acute Lymphoblastic Leukemia Trial in Hanoi (anti-CD19 CAR T-cells)

    Recruiting
    • B-Cell Non Hodgkin Lymphoma
    • B-Cell Acute Lymphoblastic Leukemia
    • anti-CD19 CAR T-cells
    • Hanoi, Vietnam
      Vinmec Research Institute of Stem Cell and Gene Technology
    Sep 5, 2023

    B-cell Acute Lymphoblastic Leukemia, B-ALL Trial in Kunming (U-CAR-T Cells (LstCAR019))

    Withdrawn
    • B-cell Acute Lymphoblastic Leukemia
    • B-ALL
    • U-CAR-T Cells (LstCAR019)
    • Kunming, Yunnan, China
      Kunming Hope of Health Hospital
    Nov 27, 2022

    B-cell Acute Lymphoblastic Leukemia, B-ALL Trial in Kunming (UCAR-T Cells)

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • B-ALL
    • UCAR-T Cells
    • Kunming, Yunnan, China
      920th Hospital of Joint Logistics Support Force of People's Libe
    Dec 7, 2022

    T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)

    Not yet recruiting
    • T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
    • CD7-CART01
    • (no location specified)
    Sep 26, 2023

    B-Cell Leukemia, B-Cell Lymphoma, B-cell Tumors Trial in Kunming (Anti-CD19 Autologous CAR-T Cell Infusion)

    Recruiting
    • B-Cell Leukemia
    • +2 more
    • Anti-CD19 Autologous CAR-T Cell Infusion
    • Kunming, Yunnan, China
      920th Hospital of Joint Logistics Support Force of People's Libe
    Jul 9, 2023

    "Don't Eat me" Signal in Hematological Malignancies: CD24 as New

    Recruiting
    • Mantle-cell Lymphoma
    • B Cell Chronic Lymphocytic Leukemia
      • Monza, MB, Italy
        Andrea Aroldi
      May 24, 2023

      Recurrent Acute Lymphoblastic Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Prolymphocytic Leukemia Trial

      Recruiting
      • Recurrent Acute Lymphoblastic Leukemia
      • +15 more
      • Anti-CD19/CD20/CD22 CAR T-Cells
      • +2 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Nov 4, 2022

      Relapsed and/or Refractory Acute Myeloid Leukemia, High Risk Hematologic Malignancies Trial in Langfang (anti-CD33 CAR T cells)

      Not yet recruiting
      • Relapsed and/or Refractory Acute Myeloid Leukemia
      • High Risk Hematologic Malignancies
      • anti-CD33 CAR T cells
      • Langfang, Hebei, China
        Hebei Yanda Lu Daopei Hospital
      Jun 30, 2022

      Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Recurrent Chronic Myelomonocytic Leukemia Trial in Houston

      Recruiting
      • Chronic Myelomonocytic Leukemia
      • +5 more
      • Canakinumab
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 7, 2022

      Leukemia, Myeloid, Acute Trial in United States (VCAR33)

      Not yet recruiting
      • Leukemia, Myeloid, Acute
      • VCAR33
      • La Jolla, California
      • +9 more
      Aug 14, 2023